Open Access Research

Engineering of daidzein 3’-hydroxylase P450 enzyme into catalytically self-sufficient cytochrome P450

Kwon-Young Choi1, EunOk Jung1, Da-Hye Jung1, Byeo-Ri An1, Bishnu P Pandey1, Hyungdon Yun2, Changmin Sung3, Hyung-Yeon Park4* and Byung-Gee Kim1*

Author Affiliations

1 School of Chemical and Biological Engineering, Institute of Bioengineering, Seoul National University, Seoul, South Korea

2 School of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk, South Korea

3 Interdisciplinary Program for Bioengineering, Seoul National University, Seoul, 151-744, Republic of Korea

4 Korea Bio-Hub Center, Bio-MAX Institute, Seoul National University, Seoul, South Korea

For all author emails, please log on.

Microbial Cell Factories 2012, 11:81 doi:10.1186/1475-2859-11-81

Published: 14 June 2012

Abstract

A cytochrome P450 (CYP) enzyme, 3’-daidzein hydroxylase, CYP105D7 (3’-DH), responsible for daidzein hydroxylation at the 3’-position, was recently reported. CYP105D7 (3’-DH) is a class I type of CYP that requires electrons provided through electron transfer proteins such as ferredoxin and ferredoxin reductase. Presently, we constructed an artificial CYP in order to develop a reaction host for the production of a hydroxylated product. Fusion-mediated construction with the reductase domain from self-sufficient CYP102D1 was done to increase electron transfer efficiency and coupling with the oxidative process. An artificial self-sufficient daidzein hydroxylase (3’-ASDH) displayed distinct spectral properties of both flavoprotein and CYP. The fusion enzyme catalyzed hydroxylation of daidzein more efficiently, with a kcat/Km value of 16.8 μM-1 min-1, which was about 24-fold higher than that of the 3’-DH-camA/B reconstituted enzyme. Finally, a recombinant Streptomyces avermitilis host for the expression of 3’-ASDH and production of the hydroxylated product was developed. The conversion that was attained (34.6%) was 5.2-fold higher than that of the wild-type.

Keywords:
Cytochrome P450 monooxygenases; Daidzein 3’-hydroxylase; Self-sufficient P450; CYP102D1